Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:GMRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGMREGlobal Medical REIT$31.88-0.2%$35.03$30.09▼$48.05$426.53M1.19143,609 shs167,893 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGMREGlobal Medical REIT0.00%+3.65%-15.35%-10.79%-33.44%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGMREGlobal Medical REIT$31.88-0.2%$35.03$30.09▼$48.05$426.53M1.19143,609 shs167,893 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGMREGlobal Medical REIT0.00%+3.65%-15.35%-10.79%-33.44%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGMREGlobal Medical REIT 2.71Moderate Buy$42.5033.32% UpsideCurrent Analyst Ratings BreakdownLatest GMRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/13/2025GMREGlobal Medical REITCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeOutperform10/13/2025GMREGlobal Medical REITJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetMarket Perform ➝ Market Outperform$40.0010/13/2025GMREGlobal Medical REITCitizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$40.0010/8/2025GMREGlobal Medical REITWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/27/2025GMREGlobal Medical REITWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/24/2025GMREGlobal Medical REITZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 10/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGMREGlobal Medical REIT$138.78M3.07$4.85 per share6.57$36.00 per share0.89Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGMREGlobal Medical REIT$6.63M$0.3591.0837.95N/A7.32%2.21%0.82%11/4/2025 (Confirmed)Latest GMRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/4/2025Q3 2025GMREGlobal Medical REIT$1.05N/AN/AN/A$38.15 millionN/A8/5/2025Q2 2025GMREGlobal Medical REIT$1.15$1.15N/A$0.23$35.57 million$37.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGMREGlobal Medical REIT$3.009.40%N/A857.14%N/ALatest GMRE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/3/2025GMREGlobal Medical REITquarterly$0.759.13%9/29/20259/29/202510/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGMREGlobal Medical REIT1.560.280.28Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGMREGlobal Medical REIT57.52%Insider OwnershipCompanyInsider OwnershipGMREGlobal Medical REIT8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGMREGlobal Medical REIT3013.38 million12.24 millionOptionableGMRE HeadlinesRecent News About These CompaniesGlobal Medical: This REIT Just Got a 30% Price Target...October 20 at 8:10 AM | marketbeat.comCreative Media & Community Trust Corporation (NASDAQ:CMCT) & Global Medical REIT (NYSE:GMRE) Financial ContrastOctober 18 at 2:54 AM | americanbankingnews.comGlobal Medical REIT (NYSE:GMRE) Upgraded to Hold at Wall Street ZenOctober 18 at 2:42 AM | marketbeat.com3 Dividend REITs Yielding Over 8% That Wall Street LovesOctober 17 at 11:00 AM | 247wallst.comGlobal Medical REIT Inc. Announces Dates for 2025 Third Quarter Earnings Release and WebcastOctober 15, 2025 | businesswire.comCitizens Jmp Upgrades Global Medical REIT (NYSE:GMRE) to "Outperform"October 15, 2025 | americanbankingnews.comJMP Securities Upgrades Global Medical REIT (GMRE)October 14, 2025 | msn.comGlobal Medical REIT upgraded to Outperform from Market Perform at Citizens JMPOctober 13, 2025 | msn.comGlobal Medical REIT raised to Buy-equivalent at CitizensOctober 13, 2025 | msn.comGlobal Medical REIT (NYSE:GMRE) Stock Rating Upgraded by Citizens JmpOctober 13, 2025 | marketbeat.comWeiss Ratings Reaffirms "Hold (C-)" Rating for Global Medical REIT (NYSE:GMRE)October 9, 2025 | marketbeat.comGlobal Medical REIT Inc. Amends and Restates Credit FacilityOctober 8, 2025 | businesswire.comGlobal Medical REIT Inc. (NYSE:GMRE) Given Consensus Recommendation of "Moderate Buy" by BrokeragesOctober 3, 2025 | marketbeat.comGlobal Medical REIT Inc. (NYSE:GMRE) Short Interest Down 79.2% in SeptemberOctober 1, 2025 | marketbeat.comGlobal Medical REIT (GMRE) Price Target Increased by 400.00% to 45.74September 30, 2025 | msn.comGlobal Medical REIT (NYSE:GMRE) Rating Increased to Strong-Buy at Zacks ResearchSeptember 26, 2025 | marketbeat.comGlobal Medical REIT (NYSE:GMRE) Stock Price Down 5.8% - What's Next?September 23, 2025 | marketbeat.comGlobal Medical REIT (NYSE:GMRE) Hits New 52-Week High - Here's What HappenedSeptember 22, 2025 | marketbeat.comGlobal Medical REIT Inc. Completes One-for-Five Reverse Stock SplitSeptember 19, 2025 | finance.yahoo.comGlobal Medical REIT Inc. Completes One-for-Five Reverse Stock SplitSeptember 19, 2025 | businesswire.comGlobal Medical REIT declares $0.15 dividendSeptember 3, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025October’s Top 5 Stocks Poised for Big BreakoutsBy Thomas Hughes | October 1, 2025Costco Investors Will Get a “Special” Treat for ChristmasBy Thomas Hughes | September 29, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 2025Global Medical: This REIT Just Got a 30% Price TargetBy Sam Quirke | October 20, 2025GMRE Company DescriptionsGlobal Medical REIT NYSE:GMRE$31.88 -0.07 (-0.23%) Closing price 03:59 PM EasternExtended Trading$31.89 +0.01 (+0.04%) As of 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Waymo’s Global Expansion Strengthens the Case for GOOGL Stock Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Meta vs OpenAI: Is Sora a True Threat to Meta's Dominance? Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall? Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up This Less-Hyped Tech Stock Could Be the Key to the Next AI Wave Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
